| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
84 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
74 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
85 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
115 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
48 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
157 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
202 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
32 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
58 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
267 |
| 424/264.1 |
Mycoplasma |
53 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
102 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
92 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
86 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
93 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
146 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
120 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
318 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
371 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
100 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
87 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7628992 |
Modification of clostridial toxins for use as transport proteins |
Dec. 8, 2009 |
| 7625572 |
Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria |
Dec. 1, 2009 |
| 7625567 |
Induction of immune responses to isoaspartyl-modified antigens |
Dec. 1, 2009 |
| 7625559 |
Antibodies against Clostridium difficile toxins and uses thereof |
Dec. 1, 2009 |
| 7622571 |
Methods and compositions for Mycoplasma pneumoniae exotoxins |
Nov. 24, 2009 |
| 7622128 |
Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
Nov. 24, 2009 |
| 7622124 |
Mycoplasma hyopneumoniae bacterin vaccine |
Nov. 24, 2009 |
| 7618636 |
Antigenic meningococcal peptides |
Nov. 17, 2009 |
| 7615222 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Nov. 10, 2009 |
| 7608450 |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
Oct. 27, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608266 |
Yersinia species compositions |
Oct. 27, 2009 |
| 7608256 |
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
Oct. 27, 2009 |
| 7608247 |
Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation |
Oct. 27, 2009 |
| 7608246 |
Apolipoprotein E as an adjuvant for lipid antigens |
Oct. 27, 2009 |
| 7604953 |
Bioamplification for microbial sensor signal transduction |
Oct. 20, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7597891 |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
Oct. 6, 2009 |
| 7595383 |
Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
Sep. 29, 2009 |
| 7592158 |
BASB019 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses |
Sep. 22, 2009 |
| 7592135 |
High resolution typing system for pathogenic Mycobacterium tuberculosum |
Sep. 22, 2009 |
| 7592008 |
Membrane scaffold proteins |
Sep. 22, 2009 |
| 7588774 |
Molecules enhancing dermal delivery of influenza vaccines |
Sep. 15, 2009 |
| 7585510 |
Vaccine |
Sep. 8, 2009 |
| 7582305 |
Antidiarrheal agent for livestock and poultry |
Sep. 1, 2009 |
| 7582304 |
Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans |
Sep. 1, 2009 |
| 7582300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
Sep. 1, 2009 |
| 7579182 |
Use of cross-protection to identify novel vaccine candidates for infectious agents |
Aug. 25, 2009 |
| 7579141 |
Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
Aug. 25, 2009 |
| 7579012 |
Targeting of triacylglycerol synthase gene for tuberculosis treatment |
Aug. 25, 2009 |
| 7579011 |
Exoenzyme toxin of Aeromonas salmonicida, and uses therefor |
Aug. 25, 2009 |
| 7579010 |
Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin |
Aug. 25, 2009 |
| 7579009 |
Whole bacterial cells as immune modulator |
Aug. 25, 2009 |
| 7579005 |
Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags |
Aug. 25, 2009 |
| 7576176 |
Neisseria meningitidis antigens and compositions |
Aug. 18, 2009 |
| 7576066 |
Nucleic acid compositions for stimulating immune responses |
Aug. 18, 2009 |
| 7575877 |
Method of diagnosing tuberculosis |
Aug. 18, 2009 |
| 7575754 |
Avian E. coli vaccine for protection against colibacillosis |
Aug. 18, 2009 |
| 7572457 |
Use of Streptococcus suis 38 kDa polypeptide as an immunogen |
Aug. 11, 2009 |
| 7569553 |
Nucleic acid compositions for stimulating immune responses |
Aug. 4, 2009 |
| 7569226 |
Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
Aug. 4, 2009 |
| 7566459 |
Modified mycobacterium tuberculosis strains and uses thereof |
Jul. 28, 2009 |
| 7563878 |
Bacterial phytases and method for producing same |
Jul. 21, 2009 |
| 7556816 |
Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family |
Jul. 7, 2009 |
| 7556810 |
Compositions and methods to control angiogenesis with cupredoxins |
Jul. 7, 2009 |
| 7553490 |
Vaccines against Escherichia coli O157 infection |
Jun. 30, 2009 |
| 7550270 |
Ileitis diagnostic assay |
Jun. 23, 2009 |
| 7547527 |
Use of probiotic lactic acid bacteria for balancing the skin's immune system |
Jun. 16, 2009 |
| 7541041 |
Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans |
Jun. 2, 2009 |
| 7541039 |
Immunization with bacterial ghost-based vaccines |
Jun. 2, 2009 |
|
|
|
